Sirnaomics, Inc.
10Patents
10Active
10Granted
48Portfolio score
Filing activity: Nov 4, 2005 → Apr 13, 2022 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11058779B2 | Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection | Chemistry; Metallurgy | 15 | Active |
| US9642873B2 | Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application | Chemistry; Metallurgy | 3 | Active |
| US8691781B2 | Compositions for treating respiratory viral infections and their use | Chemistry; Metallurgy | 1 | Active |
| US12006500B2 | Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) | Chemistry; Metallurgy | 1 | Active |
| USRE46873E1 | Multi-targeted RNAi therapeutics for scarless wound healing of skin | General | 1 | Active |
| US9506063B2 | SiRNA compositions and methods for treatment of HPV and other infections | Chemistry; Metallurgy | 0 | Active |
| US12378552B2 | Oligomeric compound for inhibiting expression of factor XI | Chemistry; Metallurgy | 0 | Active |
| US11697813B2 | Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis | Chemistry; Metallurgy | 0 | Active |
| US12054714B2 | Peptide docking vehicle for targeted nucleic acid delivery | Chemistry; Metallurgy | 0 | Active |
| US9868952B2 | Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.